Investment

Nanopath Raises $10M in Series A Funding to Develop and Commercialize Point-of-Care Diagnostics for Women’s Health

 Nanopath, a molecular diagnostics company enabling high-quality molecular testing in minutes, has raised $10M in Series A funding, co-led by Norwest Venture Partners and the Medtech Convergence Fund. Other participants in the round include Gingerbread Capital and Green D Ventures. The new funds will support development and commercialization of Nanopath’s biosensing platform that aims to transform how women’s pelvic and gynecologic infections are diagnosed. Amogha…

Femtech Investment Round-up: July 2022

At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is July 2022’s round-up. Investments Male contraception company YourChoice Therapeutics adds $15M in Series A funding to kick off human trials. You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on:…

Male Contraception Company YourChoice Therapeutics Adds $15M in Series A Funding to Kick Off Human Trials

YourChoice Therapeutics, a biotech company developing new contraceptives for men has raised $15M in Series A funding led by Future Ventures with participation from North South Ventures, RH Capital and Olive Tree Capital. According to reporting the company will use the new funds to conduct its first human trials. YourChoice Therapeutics got started in 2018, initially with the goal to develop a…

Caraway, A Digital Health Startup Targeting College Women, Comes Out of Stealth with $10.5M in Funding

Caraway, a femtech with plans to take on the societal and medical imperative of caring for college students by providing integrated mental, reproductive and physical healthcare has come out of stealth announcing a $10.5M seed round.  The company was hatched through a partnership between 7wireVentures, OMERS Ventures, and veteran digital health leaders Lori Evans Bernstein and Joshua Tauber. The round was led by 7wireVentures and OMERS Ventures,…

Menopause Startup Lisa Health Launches Its New “Midday” App After Raising $2.5M in Seed Funding

Menopause startup Lisa Health has raised $2.5M in seed funding led by Radical Ventures and announced the launch of its new app, Midday, which has been created in collaboration with Mayo Clinic. Other investors in the round include SRI International and Broadway Angels. The Midday app leverages AI, sensor technology and digital therapeutics to support women on their menopause journey. By 2030,…

The Lowdown Raises $2.5M in Seed Funding to Scale Its Contraception Review Platform in Europe

U.K.-based Contraception review platform The Lowdown has raised $2.5M in seed funding led by Speedinvest, who are joining joining existing investors Nina Capital, Calm/Storm VC, Entrepreneur First and four Atomico Angels. The Lowdown was founded by by Alice Pelton after suffering debilitating side effects from her contraception throughout her twenties. 78% of the 1 billion people worldwide who use contraception, experience side…

Arise Launches Its Platform for Inclusive Eating Disorder Treatment with $4M in Seed Funding

Arise, the digital healthcare company enabling comprehensive care for eating disorders, mental health, and long-term healing, has launched today after raising over $4M in a seed funding round. Arise is building a virtual-first care model to reach and engage more of the 30 million Americans who will experience an eating disorder in their lifetime — 80-90% of whom will not get care today.…

Choix Raises $1M in Funding to Expand Access to Abortion, Sexual and Reproductive Healthcare

Choix, a telehealth clinic focused on abortion, sexual and reproductive healthcare, secured $1 million in its initial seed round. The first round of funding was led by Elevate Capital, a venture capital fund. Choix plans to raise an additional $500,000 to $1 million in the coming months. “We’re incredibly grateful to Elevate for believing in our mission to improve access to safe abortion care from home,” says Cindy Adam,…